Investor Relations
Investor Relations Contact:
LHA
Anne Marie Fields
212-838-3777
afields@lhai.com
or
Bruce Voss
310-691-7100
bvoss@lhai.com

Media Contact
Rooney & Associates
Terry Rooney
212-223-0689
trooney@rooneyco.com
or
Marion Janic
212-223-4017
mjanic@rooneyco.com

OPKO Health Enters into Exclusive Agreement with Japan Tobacco to Develop and Commercialize RAYALDEE® in Japan more »

OPKO's BioReference Laboratories and The Garage Announce National Strategic Affiliation to Enhance Value-Based Care more »

OPKO's GeneDx to Showcase Leadership in Genetic Testing at the National Society of Genetic Counselors and the American Society of Human Genetics Annual Meetings more »

OPKO Health to Present at Upcoming September Conferences more »

Code of Business Conduct and Ethics

Code of Business Conduct and Ethics Introduction

The Board has adopted a Code of Business Conduct and Ethics that applies to all of our directors, officers (including our Chief Executive Officer, our Chief Financial Officer, and our principal accounting officer), and employees.

Notice of Amendment:
On June 14, 2012, the Company's Board of Directors amended its Code of Business Conduct and Ethics to, among other things, further define various transactions which would constitute a conflict of interest, include provisions prohibiting usurpation of corporate opportunities, impose requirements of fair dealing and confidentiality, and clarify various reporting procedures and obligations for responding to government investigations and media or public inquiries.


PDF Click here for OPKO's Code of Business Conduct and Ethics   1.6 MB

Email  Sign up for email alerts